NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

  • September 2019: Recommendation 1.9.21 on stopping antidepressants has been replaced by NICE and a new recommendation 1.9.22 added, and subsequent recommendations renumbered. This is to bring the advice in this section in line with current practice. April 2018: Warnings have been added to link to the MHRA's latest advice and resources on sodium valproate. Sodium valproate must not be used in pregnancy, and only used in girls and women when there is no alternative and a pregnancy prevention plan is in place. This is because of the risk of malformations and developmental abnormalities in the baby.

September 2019: Recommendation 1.9.21 on stopping antidepressants has been replaced by NICE and a new recommendation 1.9.22 added, and subsequent recommendations renumbered. This is to bring the advice in this section in line with current practice. April 2018: Warnings have been added to link to the MHRA's latest advice and resources on sodium valproate. Sodium valproate must not be used in pregnancy, and only used in girls and women when there is no alternative and a pregnancy prevention plan is in place. This is because of the risk of malformations and developmental abnormalities in the baby.

Cover of Depression

Depression

The Treatment and Management of Depression in Adults (Updated Edition)

NICE Clinical Guidelines, No. 90

.

Leicester (UK): British Psychological Society; .
ISBN-13: 978-1-904671-85-5

This clinical guideline on depression is an updated edition of the previous guidance (published in 2004). It was commissioned by NICE and developed by the National Collaborating Centre for Mental Health, and sets out clear, evidence- and consensus-based recommendations for healthcare staff on how to treat and manage depression in adults.

Depression affects 6% of adults each year and is the leading cause of suicide. Its symptoms can be disabling and its effects pervasive, impacting on not only the individual patient but also on their families and the wider society. The NICE guideline is an invaluable resource enabling healthcare professionals to recognise, assess and offer effective treatments for this common mental health problem, which can become a chronic disorder if inadequately treated.

Many areas of the previous guideline have been updated in this edition. There is a new introduction about depression and current practice, and a new chapter on service user and carer experience of care. The evidence reviews of service models and psychological and psychosocial interventions have all been updated and there is a new emphasis on low-intensity psychosocial interventions and an increased range of effective psychological interventions. The chapters on pharmacological interventions provide more detailed advice on sequencing treatments after limited response to initial interventions. This new edition of the guideline also covers the management of subthreshold depressive symptoms, which was not part of the scope of the previous guideline.

Contents

The views presented in this book do not necessarily reflect those of the British Psychological Society, and the publishers are not responsible for any error of omission or fact. The British Psychological Society is a registered charity (no. 229642).

Copyright © The British Psychological Society & The Royal College of Psychiatrists, 2010.

All rights reserved. No part of this book may be reprinted or reproduced or utilised in any form or by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying and recording, or in any information storage or retrieval system, without permission in writing from the publishers. Enquiries in this regard should be directed to the British Psychological Society.

Bookshelf ID: NBK63748PMID: 22132433

Views

Similar articles in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...